AB SCIEX and Phenomenex Partner to Improve Food Safety Testing
AB SCIEX (Framingham, Massachusetts), and Phenomenex (Torrance, California) are collaborating to improve food testing.
AB SCIEX (Framingham, Massachusetts), and Phenomenex (Torrance, California) are collaborating to improve food testing. The creation of a joint rapid response team responsible for developing highest-quality, most cost-effective methods is a key component of the collaboration. The partnership is expected to support efforts to prevent the spread of tainted food and help increase safety of the global food supply.
To address the worldwide demand in the food testing community for methods for faster response, higher quality results, and less expensive tests, scientists from both companies will work closely with food industry experts in applications such as pesticides, antibiotics, allergens, and natural toxins.
The companies will combine expertise and resources to form a global rapid response unit comprised of personnel from Phenomenex’s method development research team, and AB SCIEX’s total solutions group. Food testing scientists and analysts will be able to access the resource via the Internet.
Among the food testing application-specific experts who are part of the joint network of independent scientists working with these companies to help shape new method development is Dr. Michael Quilliam at the National Research Council of Canada in Halifax. He is a recognized expert on shellfish toxin analysis.
RAFA 2024: Giorgia Purcaro on Multidimensional GC for Mineral Oil Hydrocarbon Analysis
November 27th 2024Giorgia Purcaro from the University of Liège was interviewed at RAFA 2024 by LCGC International on the benefits of modern multidimensional GC methods to analyze mineral oil aromatic hydrocarbons (MOAH) and mineral oil saturated hydrocarbons (MOSH).
AI and GenAI Applications to Help Optimize Purification and Yield of Antibodies From Plasma
October 31st 2024Deriving antibodies from plasma products involves several steps, typically starting from the collection of plasma and ending with the purification of the desired antibodies. These are: plasma collection; plasma pooling; fractionation; antibody purification; concentration and formulation; quality control; and packaging and storage. This process results in a purified antibody product that can be used for therapeutic purposes, diagnostic tests, or research. Each step is critical to ensure the safety, efficacy, and quality of the final product. Applications of AI/GenAI in many of these steps can significantly help in the optimization of purification and yield of the desired antibodies. Some specific use-cases are: selecting and optimizing plasma units for optimized plasma pooling; GenAI solution for enterprise search on internal knowledge portal; analysing and optimizing production batch profitability, inventory, yields; monitoring production batch key performance indicators for outlier identification; monitoring production equipment to predict maintenance events; and reducing quality control laboratory testing turnaround time.
Identifying Antioxidative Properties in Berries with UHPLC-MS
Published: November 27th 2024 | Updated: November 27th 2024A recent study identified and quantified anthocyanin (which are known for their antioxidative properties and potential effectiveness against depression) in blueberries, blackberries, black mulberries, and cranberries using ultra high-pressure liquid chromatography (UHPLC) followed by in vivo evaluation of their antidepressant-like activities.
In Conversation with the EAS Award Winner for Outstanding Achievements in Mass Spectrometry
November 27th 2024As part of our EAS 2024 coverage, we recently interviewed Benjamin Garcia of the Washington University in St. Louis about his work and his being awarded the EAS Award for Outstanding Achievements in Mass Spectrometry.
